Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trialJeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon, Carlos Becerra, Douglas J. DeMarini, Donna S. Cox, Yanmei Xu, Shannon R. Morris, Vijay Peddareddigari, Ngocdiep T. Le, Lowell L. Hart, Johanna C. Bendell, Gail Eckhardt, Razelle Kurzrock, Keith T. Flaherty, Howard A. Burris, Wells A. Messersmith
The Lancet Oncology. 2012559 Citations
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trialGerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap, Vijay Peddareddigari, Peter F. Lebowitz, Ngocdiep T. Le, Howard A. Burris, Wells A. Messersmith, Peter J. O’Dwyer, Kevin B. Kim, Keith T. Flaherty, Johanna C. Bendell, René González, Razelle Kurzrock, Leslie A. Fecher
The Lancet Oncology. 2012545 CitationsOPEN ACCESS
NeuropsychopharmacologyAnne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Mohammed Shoaib, Barbara J. Mason, Charles J. Heyser, Luı́s de Lecea, Robert L. Balster, Sharon Walsh, Megan M. Dahmen, Jana Lincoln, Sheldon Preskorn, Roshan Cools, María Isabel Colado, Richard Green, Luis Stinus, Stéphanie Caillé, Martine Cador, Marie-Louise G. Wadenberg, Samuel G. Siris, Seiya Miyamoto, Alex Hofer, Linda P. Spear, A. Claudio Cuello, A. Leslie Morrow, Patrizia Porcu, Marilyn E. Carroll, Peter A. Santi, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Peter Riederer, Siegfried Hoyer, Wiepke Cahn, Heleen B. M. Boos, H D Postma, R. H. De Rijk, E. R Kloet, Sharon Morein‐Zamir, Barbara J. Sahakian, Peter Riederer, Siegfried Hoyer, J. M. Bessa, Osborne F. X. Almeida, N. Sousa, Wiepke Cahn, Heleen B. M. Boos, H D Postma, R. Andrew Chambers, Caroline Cohen, Marc Turiault, Guy Griebel, Caroline Cohen, Marc Turiault, Guy Griebel, Wolfgang Fleischhacker, Alfonso Abizaid, Shimon Amir, Jaanus Harro, Peter Verheart, Per Svenningsson, Per E. Andrén, R. Andrew Chambers, Kenneth J. Rhodes, A. Richard Green, María Isabel Colado, María Isabel Colado, Richard Green, Christof Baltes, Thomas Mueggler, Markus Rudin, Lucy C. Guillory, Becky Kinkead, Charles B. Nemeroff, Wiepke Cahn, Heleen B. M. Boos, H D Postma, Heleen B. M. Boos, H. D. Postma, Wiepke Cahn, Stephen B. Dunnett, Michael J. Kuhar, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Stephen M. Stahl, Meghan M. Grady, Jean‐Michel Scherrmann, Arthur Christopoulos, Gregory D. Stewart, Patrick M. Sexton, Jelena Nešić, Theodora Duka, Paul B. S. Clarke, Maxine L. Stitzer, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Hans Rollema, Daniel Bertrand
2010323 Citations
Effects of Lower-Cost Incentives on Stimulant Abstinence in Methadone Maintenance TreatmentJessica M. Peirce, Nancy M. Petry, Maxine L. Stitzer, Jack Blaine, Scott Kellogg, Frank Satterfield, Marion Schwartz, Joe Krasnansky, Eileen Pencer, Lolita Silva-Vazquez, Kimberly C. Kirby, Charlotte Royer-Malvestuto, John M. Roll, Allan Cohen, Marc L. Copersino, Ken Kolodner, Rui Li
Archives of General Psychiatry. 2006308 Citations